|
1
|
Sun S, Schiller JH and Gazdar AF: Lung
cancer in never smokers - a different disease. Nat Rev Cancer.
7:778–790. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spiro SG and Silvestri GA: One hundred
years of lung cancer. Am J Respir Crit Care Med. 172:523–529. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spiro SG, Tanner NT, Silvestri GA, Janes
SM, Lim E, Vansteenkiste JF and Pirker R: Lung cancer: Progress in
diagnosis, staging and therapy. Respirology. 15:44–50. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cancer Genome Atlas Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agre P, King LS, Yasui M, Guggino WB,
Ottersen OP, Fujiyoshi Y, Engel A and Nielsen S: Aquaporin water
channels - from atomic structure to clinical medicine. J Physiol.
542:3–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Verkman AS and Mitra AK: Structure and
function of aquaporin water channels. Am J Physiol Renal Physiol.
278:F13–F28. 2000.PubMed/NCBI
|
|
8
|
Mobasheri A, Airley R, Hewitt SM and
Marples D: Heterogeneous expression of the aquaporin 1 (AQP1) water
channel in tumors of the prostate, breast, ovary, colon and lung: A
study using high density multiple human tumor tissue microarrays.
Int J Oncol. 26:1149–1158. 2005.PubMed/NCBI
|
|
9
|
Moon C, Soria JC, Jang SJ, Lee J, Obaidul
Hoque M, Sibony M, Trink B, Chang YS, Sidransky D and Mao L:
Involvement of aquaporins in colorectal carcinogenesis. Oncogene.
22:6699–6703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saadoun S, Papadopoulos MC, Davies DC,
Krishna S and Bell BA: Aquaporin-4 expression is increased in
oedematous human brain tumours. J Neurol Neurosurg Psychiatry.
72:262–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kafé H, Verbavatz JM, Cochand-Priollet B,
Castagnet P and Vieillefond A: Collecting duct carcinoma: An entity
to be redefined? Virchows Arch. 445:637–640. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mazal PR, Stichenwirth M, Koller A, Blach
S, Haitel A and Susani M: Expression of aquaporins and PAX-2
compared to CD10 and cytokeratin 7 in renal neoplasms: A tissue
microarray study. Mod Pathol. 18:535–540. 2005. View Article : Google Scholar
|
|
13
|
Hara-Chikuma M and Verkman AS: Aquaporin-1
facilitates epithelial cell migration in kidney proximal tubule. J
Am Soc Nephrol. 17:39–45. 2006. View Article : Google Scholar
|
|
14
|
Hara-Chikuma M and Verkman AS: Aquaporin-3
facilitates epidermal cell migration and proliferation during wound
healing. J Mol Med (Berl). 86:221–231. 2008. View Article : Google Scholar
|
|
15
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ruiz-Ederra J and Verkman AS:
Aquaporin-1-facilitated keratocyte migration in cell culture and in
vivo corneal wound healing models. Exp Eye Res. 89:159–165. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayashi S, Takahashi N, Kurata N,
Yamaguchi A, Matsui H, Kato S and Takeuchi K: Involvement of
aquaporin-1 in gastric epithelial cell migration during wound
repair. Biochem Biophys Res Commun. 386:483–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. FASEB J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barabutis N and Schally AV: Knocking down
gene expression for growth hormone-releasing hormone inhibits
proliferation of human cancer cell lines. Br J Cancer.
98:1790–1796. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Janssen-Heijnen ML and Coebergh JW: The
changing epidemiology of lung cancer in Europe. Lung Cancer.
41:245–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Devesa SS, Bray F, Vizcaino AP and Parkin
DM: International lung cancer trends by histologic type: male:
female differences diminishing and adenocarcinoma rates rising. Int
J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Y: Aquaporin-1 activity of plasma
membrane affects HT20 colon cancer cell migration. IUBMB Life.
61:1001–1009. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Otterbach F, Callies R, Adamzik M, Kimmig
R, Siffert W, Schmid KW and Bankfalvi A: Aquaporin 1 (AQP1)
expression is a novel characteristic feature of a particularly
aggressive subgroup of basal-like breast carcinomas. Breast Cancer
Res Treat. 120:67–76. 2010. View Article : Google Scholar
|
|
25
|
Pan H, Sun CC, Zhou CY and Huang HF:
Expression of aquaporin-1 in normal, hyperplasic, and carcinomatous
endometria. Int J Gynaecol Obstet. 101:239–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoque MO, Soria JC, Woo J, Lee T, Lee J,
Jang SJ, Upadhyay S, Trink B, Monitto C, Desmaze C, et al:
Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3
cell proliferation and anchorage-independent growth. Am J Pathol.
168:1345–1353. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Andersen P, Villingshøj M, Poulsen HS and
Stockhausen MT: Improved response by co-targeting EGFR/EGFRvIII and
Src family kinases in human cancer cells. Cancer Invest.
27:178–183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shankardas J, Patil RV and Vishwanatha JK:
Effect of downregulation of aquaporins in human corneal endothelial
and epithelial cell lines. Mol Vis. 16:1538–1548. 2010.PubMed/NCBI
|
|
29
|
Yu JL, May L, Lhotak V, Shahrzad S,
Shirasawa S, Weitz JI, Coomber BL, Mackman N and Rak JW: Oncogenic
events regulate tissue factor expression in colorectal cancer
cells: Implications for tumor progression and angiogenesis. Blood.
105:1734–1741. 2005. View Article : Google Scholar
|
|
30
|
Amarzguioui M, Peng Q, Wiiger MT, Vasovic
V, Babaie E, Holen T, Nesland JM and Prydz H: Ex vivo and in vivo
delivery of anti-tissue factor short interfering RNA inhibits mouse
pulmonary metastasis of B16 melanoma cells. Clin Cancer Res.
12:4055–4061. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang X, Wang M, Amarzguioui M, Liu F,
Fodstad Ø and Prydz H: Downregulation of tissue factor by RNA
interference in human melanoma LOX-L cells reduces pulmonary
metastasis in nude mice. Int J Cancer. 112:994–1002. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu C, Pan K, Xing D, Liang G, Tan W, Zhang
L and Lin D: Correlation between a single nucleotide polymorphism
in the matrix metalloproteinase-2 promoter and risk of lung cancer.
Cancer Res. 62:6430–6433. 2002.PubMed/NCBI
|
|
36
|
Chetty C, Lakka SS, Bhoopathi P and Rao
JS: MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated
PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer.
127:1081–1095. 2010. View Article : Google Scholar :
|
|
37
|
Rojiani MV, Alidina J, Esposito N and
Rojiani AM: Expression of MMP-2 correlates with increased
angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp
Pathol. 3:775–781. 2010.PubMed/NCBI
|
|
38
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miyazono K: Transforming growth
factor-beta signaling in epithelial-mesenchymal transition and
progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci.
85:314–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Massagué J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ten Dijke P, Goumans MJ and Pardali E:
Endoglin in angiogenesis and vascular diseases. Angiogenesis.
11:79–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Scagliotti GV, Selvaggi G, Novello S and
Hirsch FR: The biology of epidermal growth factor receptor in lung
cancer. Clin Cancer Res. 10:4227s–4232s. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37(Suppl 4): S9–S15. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mendelsohn J and Baselga J: The EGF
receptor family as targets for cancer therapy. Oncogene.
19:6550–6565. 2000. View Article : Google Scholar
|
|
45
|
Zhang Z, Chen Z, Song Y, Zhang P, Hu J and
Bai C: Expression of aquaporin 5 increases proliferation and
metastasis potential of lung cancer. J Pathol. 221:210–220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
